(19)
(11) EP 3 436 481 A1

(12)

(43) Date of publication:
06.02.2019 Bulletin 2019/06

(21) Application number: 17715372.3

(22) Date of filing: 24.03.2017
(51) International Patent Classification (IPC): 
C07K 16/30(2006.01)
A61P 35/00(2006.01)
C07K 16/28(2006.01)
A61K 47/68(2017.01)
(86) International application number:
PCT/US2017/024027
(87) International publication number:
WO 2017/172518 (05.10.2017 Gazette 2017/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 29.03.2016 US 201662314652 P
12.07.2016 US 201662361312 P

(71) Applicants:
  • STCUBE, INC.
    Gangnam-gu, Seoul, 06164 (KR)
  • Board Of Regents, The University Of Texas System
    Austin, TX 78701 (US)

(72) Inventors:
  • YOO, Stephen S.
    Centreville Virginia 20120 (US)
  • CHUNG, Ezra M.
    North Potomac Maryland 20878 (US)
  • KIM, Yong-Soo
    Rockville Maryland 20852 (US)
  • HAN, Kyu Lee
    Gaithersburg Maryland 20878 (US)
  • PARK, Andrew H.
    Gaithersburg Maryland 20879 (US)
  • HUNG, Mien-Chie
    Houston Texas 77096 (US)
  • LI, Chia-Wei
    Houston Texas 77030 (US)
  • LIM, Seung-Oe
    Houston Texas 77030 (US)

(74) Representative: Appleyard Lees IP LLP 
15 Clare Road
Halifax HX1 2HY
Halifax HX1 2HY (GB)

   


(54) DUAL FUNCTION ANTIBODIES SPECIFIC TO GLYCOSYLATED PD-L1 AND METHODS OF USE THEREOF